Sign Up Today and Learn More About Biofourmis Stock
Invest in or calculate the value of your shares in Biofourmis or other pre-IPO companies through EquityZen's platform.
Biofourmis Stock (BIOF)
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
About Biofourmis Stock
Founded
2015
Headquarters
Boston, MA, US
Industries
Software, Data and Analytics, Science and Engineering
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
Biofourmis Press Mentions
Stay in the know about the latest news on Biofourmis
Expiration of hospital-at-home, telehealth policies threatens nonprofit hospitals' recovery: Fitch
fiercehealthcare • Nov 23, 2024
5 New Unicorns Join The Board And 5 Exit In October
news • Nov 18, 2024
LookDeep Health Welcomes New Strategic Advisor Sarah Bell
prnewswire • Oct 31, 2024
LookDeep Health Welcomes New Strategic Advisor Sarah Bell
morningstar • Oct 31, 2024
SG-born unicorn Biofourmis merges with US healthtech firm CopilotIQ
dealstreetasia • Oct 22, 2024
Investors in Biofourmis
Discover investors in Biofourmis stock and explore their portfolio companies
Biofourmis Management
Leadership team at Biofourmis
Founder & CEO
Kuldeep Singh Rajput
CO-Founder & MD
Wendou Niu
Join now and verify your accreditation status to gain access to:
- Biofourmis current valuation
- Biofourmis stock price
- Available deals in Biofourmis and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Biofourmis Stock
How to invest in Biofourmis stock?
Accredited investors can buy pre-IPO stock in companies like Biofourmis through EquityZen funds. These investments are made available by existing Biofourmis shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Biofourmis stock?
Shareholders can sell their Biofourmis stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
